Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: Efficacy, safety, and clinical benefit assessment

✍ Scribed by E. Efstathiou; G. Bozas; A. Kostakopoulos; E. Kastritis; C. Deliveliotis; N. Antoniou; D. Skarlos; C. Papadimitriou; M.A. Dimopoulos; A. Bamias

• Book ID: 116944594
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 106 KB
• Volume: 65
• Category: Article
• ISSN: 0090-4295
• DOI: 10.1016/j.urology.2004.08.041